Anti-cancer scopes and associated mechanisms of scutellaria extract and flavonoid wogonin

Current Cancer Therapy Reviews

Volumn 9, Issue 1, 2013, Pages 34-42

  Patel, Paras S ^a   Joshee, Nirmal ^b   Rimando, Agnes M ^c   Parajuli, Prahlad ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b FORT VALLEY STATE UNIVERSITY   (United States)

^c NATURAL PRODUCTS UTILIZATION RESEARCH UNIT   (United States)

Author keywords

Cancer; Flavonoid; GSK 3; NF ?B; p38 MAPK; Scutellaria; Wogonin

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; APIGENIN; BAICALEIN; BAICALIN; BZL 101; CARCINOGEN; CHRYSIN; ESTRADIOL 17 GLUCURONIDE; FLAVONE DERIVATIVE; FLAVONOID; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; LUTEOLIN; MORPHINE 6 GLUCURONIDE; NARINGENIN; OROXYLIN A; OROXYLIN A 7 O GLUCURONIDE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; QUERCETIN; SCUTELLAREIN; SCUTELLARIA BAICALENSIS EXTRACT; SCUTELLARIA EXTRACT; SCUTELLARIA LATERIFLORA EXTRACT; SCUTELLARIAE RADIX; UNCLASSIFIED DRUG; UNINDEXED DRUG; WOGONIN; WOGONOSIDE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CELL CULTURE; CANCER RESEARCH; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHYTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; REVIEW; SCUTELLARIA; SCUTELLARIA BAICALENSIS; SCUTELLARIA LATERIFLORA; SIGNAL TRANSDUCTION;

EID: 84874859005     PISSN: 15733947     EISSN: 18756301     Source Type: Journal    
DOI: 10.2174/1573394711309010004     Document Type: Review

References (60)

1. Paton A. A global taxonomic investigation of Scutellaria. Kew Bull 1990; 45.
2. Parajuli P, Joshee N, Rimando AM, Mittal S, Yadav AK. In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med 2009; 75: 41-48.
3. Lu Y, Joerger R, Wu C. Study of the chemical composition and antimicrobial activities of ethanolic extracts from roots of Scutellaria baicalensis Georgi. J Agric Food Chem 59: 10934-42.
4. Lanier LL, Chang C, Azuma M, et al. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56). J Immunol 1991; 146: 4421-6.
5. Shi R, Qiao S, Yu D, et al. Simultaneous determination of five flavonoids from Scutellaria Barbata extract in rat plasma by LCMS/MS and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879: 1625-32.
6. Liu G, Rajesh N, Wang X, et al. Identification of flavonoids in the stems and leaves of Scutellaria baicalensis Georgi. J Chromatogr B Analyt Technol Biomed Life Sci; 879: 1023-8.
7. Yao H, Li S, Hu J, et al. Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata. Planta Med 2011; 77: 388-93.
8. Shang X, He X, Li M, et al. The genus Scutellaria an ethnopharmacological and phytochemical review. J Ethnopharmacol 2010; 128: 279-313.
9. Li-Weber M. New therapeutic aspects of flavones: the anti-cancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 2009; 35: 57-68.
10. Zhang Z, Lian XY, Li S, Stringer JL. Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora). Phytomedicine 2009; 16: 485-93.
11. Cole IB, Cao J, Alan AR, Saxena PK, Murch SJ. Comparisons of Scutellaria baicalensis, Scutellaria lateriflora and Scutellaria racemosa: genome size, antioxidant potential and phytochemistry. Planta Med 2008; 74: 474-81.
12. Winkel-Shirley B. Biosynthesis of flavonoids and effects of stress. Curr Opin Plant Biol 2002; 5: 218-23.
13. Makino T, Hishida A, Goda Y, Mizukami H. Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products. J Nat Med 2008; 62: 294-9.
14. Li C, Zhang L, Lin G, Zuo Z. Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product. J Pharm Biomed Anal 54: 750-8.
15. Parajuli P, Joshee N, Chinni SR, et al. Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NFkappaB signaling. J Neurooncol 2011; 101: 15-24.
16. Zhao L, Chen Z, Zhao Q, et al. Developmental toxicity and genotoxicity studies of wogonin. Regul Toxicol Pharmacol 2011; 60: 212-7.
17. Chung H, Jung YM, Shin DH, et al. Anti-cancer effects of wogonin in both estrogen receptor-positive and-negative human breast cancer cell lines in vitro and in nude mice xenografts. Int J Cancer 2008; 122: 816-22.
18. Gao J, Morgan WA, Sanchez-Medina A, Corcoran O. The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. Toxicol Appl Pharmacol 2011.
19. Wang CZ, Li XL, Wang QF, Mehendale SR, Yuan CS. Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells. Phytomedicine 2010; 17: 63-8.
20. Bonham M, Posakony J, Coleman I, et al. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin Cancer Res 2005; 11: 3905-14.
21. Chen V, Staub RE, Baggett S, et al. Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle. PloS one 2012; 7: e30107.
22. Schmitt-Schillig S, Schaffer S, Weber CC, Eckert GP, Muller WE. Flavonoids and the aging brain. J Physiol Pharmacol 2005; 56 (Suppl 1): 23-36.
23. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med; 31: 446-67.
24. Bourasset F, Cisternino S, Temsamani J, Scherrmann JM. Evidence for an active transport of morphine-6-beta-d-glucuronide but not Pglycoprotein-mediated at the blood-brain barrier. J Neurochem 2003; 86: 1564-7.
25. Shitara Y, Li AP, Kato Y, et al. Function of uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 2003; 18: 33-41.
26. Lu T, Song J, Huang F, et al. Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. J Ethnopharmacol 2007; 110: 412-8.
27. Walle T, Ta N, Kawamori T, et al. Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones. Biochem Pharmacol 2007; 73: 1288-96.
28. Fong S, Shoemaker M, Cadaoas J, et al. Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther 2008; 7: 577-586
29. Dai ZJ, Gao J, Li ZF, et al. In vitro and in vivo antitumor activity of Scutellaria barbate extract on murine liver cancer. Molecules 2011; 16: 4389-400
30. Shiau AL, Shen YT, Hsieh JL, Wu CL, Lee CH. Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 alpha in lung tumor. Environmental toxicology 2012.
31. Wong BY, Nguyen DL, Lin T, et al. Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 2009; 18: 331-41.
32. Ye F, Jiang S, Volshonok H, Wu J, Zhang DY. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract. Nutrition and cancer 2007; 57: 100-10
33. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2001; 2: 769-76.
34. Testa JR, Tsichlis PN. AKT signaling in normal and malignant cells. Oncogene 2005; 24: 7391-93
35. Swami M. Therapeutics: Akt: a double-edged sword. Nat Rev Cancer 2009; 9: 76-7
36. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008; 27: 6473-88.
37. Neri LM, Borgatti P, Capitani S, Martelli AM. The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 2002; 1584: 73-80.
38. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004.
39. Chen S, Cooper M, Jones M, et al. Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals. Cell Biol Toxicol 2011; 27: 133-47.
40. Chow SE, Chang YL, Chuang SF, Wang JS. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3beta and DeltaNp63. Cancer Chemother Pharmacol 2011.
41. Hutchinson E. Acting on active AKT. Nat Rev Cancer 2003; 3: 241.
42. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2: 717-26.
43. Yu JS, Kim AK. Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol Cells 2011; 31: 327-35
44. Ueng YF, Shyu CC, Lin YL, et al. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice. Life Sci 2000; 67: 2189-200
45. Dandawate S, Williams L, Joshee N, et al. Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-beta1 activity. Cancer Immunol Immunother
46. Calvert H, Azzariti A. The clinical development of inhibitors of poly(ADP-ribose) polymerase. Ann Oncol 2011; 22 (Suppl 1): i 53-9.
47. Villanueva T. Expanding the horizons of PARP inhibitors. Nat Rev Cancer 2010; 10: 814.
48. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 2010; 10: 293-301.
49. Yang L, Zheng XL, Sun H, et al. Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-kappaB activation and sensitizes apoptosis. Cancer Sci 2011; 102: 870-6.
50. Lin CC, Kuo CL, Lee MH, et al. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways. Int J Oncol 2011; 39: 217-24.
51. Chow JM, Huang GC, Shen SC, et al. Differential apoptotic effect of wogonin and nor-wogonin via stimulation of ROS production in human leukemia cells. J Cell Biochem 2008; 103: 1394-404.
52. Stockinger B, Hirota K, Duarte J, Veldhoen M. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin Immunol 2011; 23: 99-105.
53. Mukai R, Shirai Y, Saito N, et al. Suppression mechanisms of flavonoids on aryl hydrocarbon receptor-mediated signal transduction. Arch Biochem Biophys 2010; 501: 134-41.
54. Chan HY, Chen ZY, Tsang DS, Leung LK. Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities. Biomed Pharmacother 2002; 56: 269-75.
55. Singh NP, Singh UP, Hegde VL, et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NFkappaB. Mol Nutr Food Res 2011.
56. Saif MW, Lansigan F, Ruta S, et al. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine 2010; 17: 161-9.
57. Perez AT, Arun B, Tripathy D, et al. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 2010; 120: 111-8.
58. Marconett CN, Morgenstern TJ, San Roman AK, et al. BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biol Ther 2010; 10: 397-405.
59. Klawitter J, Gurshtein J, Corby K, et al. Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study. Int J Cancer 2011
60. Kim JH, Lee EO, Lee HJ, et al. Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolininduced apoptosis in Lewis lung carcinoma cells. Ann N Y Acad Sci 2007; 1095: 598-611.